Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040988 · ClinicalTrials.gov registry record
The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 166
- Enrollment target
NCT01040988: Completed study, sponsored by Boston Children's Hospital.
NCT01040988 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040988 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The introduction of pacemakers and implantable cardioverter-defibrillators (ICDs) has substantially changed the medical and surgical management of patients with cardiac rhythm disease. In the case of patients with ICDs, these devices are programmed to deliver a strong electrical shocks. In adults, multiple studies have suggested that patients at risk of receiving shocks from their device have an increased prevalence of anxiety and depression. Very few studies have looked at this question in children. We propose to evaluate a cohort of patients age 6 to 20 with ICDs, compared to a cohort of patients with pacemakers, assessing each group for the presence of depressive and anxiety disorders, including post-traumatic stress disorder (PTSD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-10 |
What the finished NCT01040988 record still lists
NCT01040988 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01040988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01040988 about?
NCT01040988 is a clinical study titled "The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study". The introduction of pacemakers and implantable cardioverter-defibrillators (ICDs) has substantially changed the medical and surgical management of patients with cardiac rhythm disease. In the case of patients with ICDs, these devices are programmed to deliver a strong electrical shocks. In adults, m...
What is the current status of trial NCT01040988?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2009-08. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT01040988?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia